• 23RD OCTOBER 2025

    Community Pharmacy England publishes draft response to pharmacist flexibilities consultation

    Pharmacist flexibilities “should be the norm”, Community Pharmacy England has said in a draft response to Government proposals. A Department of Health and Social Care’s (DHSC’s) consultation is proposing enabling community pharmacists to supply a different strength or formulation (which may mean a different quantity) of the same medicine originally prescribed where the prescribed medicine

    Read more
    • 23RD OCTOBER 2025

    October 2025 Price Concessions 2nd Update

    The Department of Health and Social Care (DHSC) has today (23/10/2025) confirmed the following list of price concessions for October 2025: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £6.85 Bumetanide 1mg tablets 28 £2.95 Buprenorphine 8mg sublingual tablets sugar free 7 £3.85 Clarithromycin 125mg/5ml oral suspension 70 £10.88 Clarithromycin 250mg/5ml oral suspension 70 £19.67 Duloxetine

    Read more
    • 23RD OCTOBER 2025

    MHRA Class 4 Medicines Notification: Various Products (Relonchem Ltd)

    MHRA Class 4 Medicines Notification: Various Products (Relonchem Ltf) Date issued: 23 October 2025 Relonchem Ltd has informed the MHRA that duplicate GTIN numbers have been assigned to certain Losartan potassium/Hydrochlorothiazide coated tablets in error and a duplicate EAN number has been assigned to certain Risperidone tablets in error. DMRC reference number: DMRC-36849945/DMRC-36701307 Marketing Authorisation

    Read more
    • 21ST OCTOBER 2025

    Primary care professions organise joint Parliamentary briefing event

    Community Pharmacy England is once again leading the organisation of a joint Parliamentary drop-in event with fellow primary care bodies, continuing a long-running collaborative partnership. Following on from last year’s successful joint event, the 2026 iteration, ‘Future of Primary Care’, will be held in January and is being co-hosted with the British Dental Association, British

    Read more
    • 20TH OCTOBER 2025

    Medicine Supply Notification: Amiodarone 100mg and 200mg tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Amiodarone 100mg and 200mg tablets MSN/2025/056 Tier 2 – medium impact Date of issue: 20th May 2025 Amiodarone 100mg and 200mg tablets are in limited supply until w/c 17 November 2025 Amiodarone suspension remains available (Specials). Unlicensed imports of amiodarone 100mg

    Read more